↓ Skip to main content

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
81 Mendeley
Title
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
Published in
Cancer Immunology, Immunotherapy, February 2019
DOI 10.1007/s00262-019-02310-2
Pubmed ID
Authors

Ernest Nadal, Bartomeu Massuti, Manuel Dómine, Rosario García-Campelo, Manuel Cobo, Enriqueta Felip

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 81 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 12%
Student > Bachelor 9 11%
Other 7 9%
Student > Ph. D. Student 6 7%
Student > Doctoral Student 5 6%
Other 11 14%
Unknown 33 41%
Readers by discipline Count As %
Medicine and Dentistry 17 21%
Biochemistry, Genetics and Molecular Biology 13 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Nursing and Health Professions 2 2%
Neuroscience 2 2%
Other 9 11%
Unknown 36 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2019.
All research outputs
#15,560,927
of 23,128,387 outputs
Outputs from Cancer Immunology, Immunotherapy
#2,175
of 2,902 outputs
Outputs of similar age
#265,230
of 437,541 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#14
of 22 outputs
Altmetric has tracked 23,128,387 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,902 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,541 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.